IP 254 (Ranitidine Hydrochloride 300 mg)
Pill with imprint IP 254 is Yellow, Capsule-shape and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Amneal Pharmaceuticals.
Ranitidine is used in the treatment of duodenal ulcer; gerd; cutaneous mastocytosis; erosive esophagitis; duodenal ulcer prophylaxis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for IP 254
Ranitidine Hydrochloride
- Imprint
- IP 254
- Strength
- 300 mg
- Color
- Yellow
- Shape
- Capsule-shape
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amneal Pharmaceuticals
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 53746-0254 | Amneal Pharmaceuticals LLC |
| 65162-0254 | Amneal Pharmaceuticals LLC |
| 42291-0725 | AvKare, Inc. |
More about ranitidine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 152 Reviews
- Drug class: H2 antagonists
- FDA Alerts (18)
Consumer resources
- Other brands
- Zantac
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.